Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,25 CAD | +2,46% | -13,79% | -46,35% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Simon Beaudoin
FOU | Founder | 40 | 18/07/17 |
Founder | 51 | 18/07/17 | |
P. Meagher
DFI | Director of Finance/CFO | 39 | 18/09/20 |
Moutih Rafei
CTO | Chief Tech/Sci/R&D Officer | 42 | 09/10/20 |
Carrie Cesarone
SEC | Corporate Secretary | 58 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Founder | 51 | 18/07/17 | |
P. Meagher
DFI | Director of Finance/CFO | 39 | 18/09/20 |
Raimar Löbenberg
CHM | Chairman | 58 | 05/01/21 |
Moutih Rafei
CTO | Chief Tech/Sci/R&D Officer | 42 | 09/10/20 |
Director/Board Member | 62 | 05/01/21 | |
Riam Shammaa
BRD | Director/Board Member | - | 09/11/21 |
Kwin Grauer
BRD | Director/Board Member | - | 09/12/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 45 536 673 | 43 386 673 ( 95,28 %) | 0 | 95,28 % |
Coordinate società
Defence Therapeutics Inc
200 Burrard Street Suite 1680
V6C 3L6, Vancouver
+
http://www.defencetherapeutics.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
-46,35% | 41,49 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione DTC
- Società Defence Therapeutics Inc.